Nathaniel John Irvine, M.D. General Practice Medicare: Medicare Enrolled Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-5000 |
Dr. Alexander Podgorski, DO General Practice Medicare: Medicare Enrolled Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-2339 |
Rachel Charlotte Ruda, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-445-2074 |
Stephen David Thrasher, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-322-9635 |
Dr. Lolita Maranan Ramos, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-8732 |
Robert Field, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-3199 |
Dr. Daniel H Ferman, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-2518 |
Mr. Benjamin Frederick Wilson, MD General Practice Medicare: Medicare Enrolled Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-2339 |
Matthew Joseph Carr, M.D. General Practice Medicare: Medicare Enrolled Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-5000 |
Sean Michael Stuart, D.O. General Practice Medicare: Accepting Medicare Assignments Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-1365 |
Dr. Wayne Robert Smith, DO General Practice Medicare: Not Enrolled in Medicare Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-1407 |
Allison Niccole Brindle, DO General Practice Medicare: Medicare Enrolled Practice Location: 620 John Paul Jones Cir Ste 275, Portsmouth, VA 23708 Phone: 757-953-2339 |
Dr. Dinchen Anna Jardine, M.D. General Practice Medicare: Medicare Enrolled Practice Location: Naval Medical Center Portsmouth, 620 John Paul Jones Circle, Portsmouth, VA 23708 Phone: 757-953-7550 Fax: 757-953-7560 |
Dr. Benjamen Philip Hall, DO General Practice Medicare: Not Enrolled in Medicare Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-3149 |
Dr. Raynido Champ, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 4440 Hatton Point Rd, Portsmouth, VA 23703 Phone: 757-483-0857 |
Taylor Zachary Duncan, DO General Practice Medicare: Not Enrolled in Medicare Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-5000 |
Dr. Justin Lee Day, D.O. General Practice Medicare: Medicare Enrolled Practice Location: 620 John Paul Jones Circle, Naval Medical Center Portsmouth, Portsmouth, VA 23708 Phone: 757-953-2518 |
Miss Erica Nicole Mingo, D,O. General Practice Medicare: Medicare Enrolled Practice Location: 620 John Paul Jones Cir, Graduate Medical Education, Portsmouth, VA 23708 Phone: 757-953-0669 |
Lovepreet Kaur, DO General Practice Medicare: Medicare Enrolled Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-2339 |
Shai Konnar Dalin Ansell, MD General Practice Medicare: Medicare Enrolled Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-2277 |
News Archive
The University of Washington and Seattle Cancer Care Alliance (SCCA) partnered to launch UW-OncoPlex - an advanced gene sequencing test to help clinicians treat cancer. The new diagnostic tool is a significant milestone in the development of precision medicine and empowers doctors to predict which treatment therapies will be most effective for an individual patient's cancer.
Vertex Pharmaceuticals Incorporated announced today that INCIVEK (telaprevir) tablets are now available in Canada for people with genotype 1 chronic hepatitis C with compensated liver disease, including cirrhosis.
Vivakor, Inc. announced today that its Board of Directors approved a dividend of shares of common stock of Regeneca International, Inc.. Vivakor previously received the shares from Regeneca in the fourth quarter of 2009 under a license agreement whereby Vivakor exclusively licensed to Regeneca, for the direct to consumer market, distribution rights to RegeneBlend, one of the new cutting-edge nutraceutical formulations developed by Vivakor.
Experts have uncovered a new molecular reason why faecal transplants are highly effective in treating infections such as C. difficile (a nasty bacteria that can infect the bowel), which could lead to more targeted treatments for this and other similar diseases.
A new study published in Seizure gives insight into the short-term outcome of patients treated for status epilepticus in Kuopio University Hospital in Finland.
› Verified 1 days ago